View Point sells tumor tissue localization devices that could complement Merit’s existing presence in the sector.
The acquisition expands Merit’s portfolio of therapeutic oncology products dedicated to the accurate diagnosis and localization of breast and soft tissue tumors.
Merit Medical acquires View Point Medical for $140M, adding innovative OneMark technology to enhance breast tumor detection and localization solutions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results